GRAIL An E3 Ubiquitin Ligase that Inhibits Cytokine Gene Transcription Is Expressed in Anergic CD4+ T Cells by Anandasabapathy, Niroshana et al.
Immunity, Vol. 18, 535–547, April, 2003, Copyright 2003 by Cell Press
GRAIL: An E3 Ubiquitin Ligase
that Inhibits Cytokine Gene Transcription
Is Expressed in Anergic CD4 T Cells
tumors (Antonia et al., 1998; Staveley-O’Carroll et al.,
1998).
Productive CD4 T cell activation leading to clonal
expansion occurs after the efficient engagement of T cell
receptor (TCR) by peptide ligand (signal one) along with
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costimulatory signals provided by APCs predominantly1Department of Medicine
via the interaction of B7 with CD28 (signal two). In con-Division of Immunology and Rheumatology
trast to T cell activation, CD4 T cell clones are rendered2 Department of Pathology
anergic when engaged by peptide bound to MHC classStanford University School of Medicine
II molecules on a planar membrane (signal one) in theStanford, California 94305
absence of costimulatory signals (signal 2) (Quill and
Schwartz, 1987). The delivery of costimulatory signals
from accessory molecules prevents the induction ofSummary
T cell anergy (Mueller et al., 1989). Additional forms of
anergy have subsequently been demonstrated in T cellsT cell anergy may serve to limit autoreactive T cell
using stimulation with plate-bound anti-CD3 mono-responses. We examined early changes in gene ex-
clonal antibodies (mAb) (Jenkins et al., 1990), antigenpression after antigen-TCR signaling in the presence
presented by APCs lacking B7 expression, stimulation(activation) or absence (anergy) of B7 costimulation.
with the calcium ionophore ionomycin (Jenkins et al.,Induced expression of GRAIL (gene related to anergy
1987), and by blocking costimulation on conventionalin lymphocytes) was observed in anergic CD4 T cells.
APCs with anti-CD28 monoclonal antibody (mAb) (Har-GRAIL is a type I transmembrane protein that localizes
ding et al., 1992). B and T cell anergy can also result fromto the endocytic pathway and bears homology to RING
low avidity antigen-TCR interactions in the presencezinc-finger proteins. Ubiquitination studies in vitro
of potential costimulation as demonstrated in double-support GRAIL function as an E3 ubiquitin ligase. Ex-
transgenic mouse models and in experiments using al-pression of GRAIL in retrovirally transduced T cell hy-
tered peptide ligands (Cooke et al., 1994; Girgis et al.,bridomas dramatically limits activation-induced IL-2
1999; Sloan-Lancaster et al., 1993).and IL-4 production. Additional studies suggest that
Anergized T cells differ markedly from activatedGRAIL E3 ubiquitin ligase activity and intact endocytic
T cells, which mount an effective proliferative response,trafficking are critical for cytokine transcriptional reg-
undergo clonal expansion, and produce robust amountsulation. Expression of GRAIL after an anergizing stimu-
of the T cell mitogenic cytokine interleukin-2 (IL-2). Inlus may result in ubiquitin-mediated regulation of pro-
contrast, anergic T cells are characterized by a failureteins essential for mitogenic cytokine expression, thus
to proliferate in response to subsequent delivery of acti-positioning GRAIL as a key player in the induction of
vation and costimulatory signals as well as by a greatlythe anergic phenotype.
diminished production of IL-2. Anergic T cells can be
restored to a responsive state by the addition of recom-Introduction
binant IL-2 to cultures during antigen rechallenge (Bev-
erly et al., 1992), and anergy induction can be preventedCD4 T lymphocytes are able to either mount an active
by signaling through the IL-2 receptor (Boussiotis etimmune response or become tolerized depending upon
al.,1994). Events correlated with anergic signaling in-
the context in which they encounter antigen displayed
clude blockade of the cell cycle in the G1 phase (Boussi-
on the surface of antigen-presenting cells (APCs). T cell
otis et al., 1994, 2000; Greenwald et al., 2001), dimin-
anergy is one form of peripheral CD4 T cell tolerance ished ras GTP binding (Fields et al., 1996), and altered
that results in nonresponsiveness to antigen recall from composition of the immunologic synapse (Eisenbraum
insufficient initial T cell costimulation. The induction of et al., 2000). The observations that CD4 T cell anergy
T cell anergy and other mechanisms of peripheral toler- induction could be inhibited by the addition of cyclohex-
ance limit the expansion of self-reactive T cells in vivo. amide or cyclosporin A suggest that anergy induction
Loss of self-tolerance contributes to the pathophysiol- is an active process, dependent upon the expression of
ogy of human autoimmune diseases including multiple newly synthesized proteins as well as intact Ca flux and
sclerosis, rheumatoid arthritis, and type I insulin-depen- calcineurin activity (Quill and Schwartz, 1987). Fusion of
dent diabetes (Ridgway et al., 1994). Conversely, T cell anergic murine T cell clones to a human Jurkat T cell
unresponsiveness to tumor antigens presents a signifi- leukemia line resulted in a dramatic block in signal trans-
cant obstacle in the immune-mediated eradication of duction to the human IL-2 gene in response to TCR
stimulation or to PMA-ionomycin, rather than resulting
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Figure 1. GRAIL Expression in In Vitro TCR-
Based T Cell Anergy
(A) SWM reactive CD4 T cell clone (3A) was
cocultured with RT 7.7 fibroblast cells lacking
B7 at a 1:1 ratio with T cells and 10 M SWM
peptide (anergic) or with RT cells expressing
MHC and B7 without peptide (resting) for 4
hr before positive selection of T cells by anti-
CD4 microbead separation. Cells were rested
overnight and rechallenged in a standard pro-
liferation assay with conventional APCs and
peptide to test the antigenic responsiveness
of selected resting or anergic cells.
(B) Murine rIL-2 was added to cultures at 5
units/ml (during antigen rechallenge) to test
proliferative capacity of these cells.
(C) Quantitative PCR analysis of SWM T cell
clone (3A) 24 hr after culture under anergic,
activated, or resting conditions.
(D) Northern analysis of GRAIL expression as-
sayed with 6 mg of total RNA from SWM T cell
clone (11.3.7) cultured under resting (lane 1),
anergic (lane 2), or activating (lane 3) condi-
tions for 4 hr. Membranes were hybridized
with a 32P-labeled 1.8 kb GRAIL cDNA frag-
ment. To control for RNA loading, membranes
were stripped and reprobed for GAPDH mRNA.
we have identified a transcript encoding a zinc binding functional anergy and not diminished viability. We also
observed that addition of anti-IL-2 monoclonal antibodyRING finger protein, GRAIL (gene related to anergy in
to T cell clones cultured under activating conditionslymphocytes). Human and mouse GRAIL share homol-
blocked proliferation in response to antigen rechallengeogy to other murine RING finger proteins as well as
(data not shown). At the time of antigen rechallenge,to those from other species including A. thaliana, D.
activated, resting, and anergized T cell clones hadmelanogaster, and C. elegans, whose functions are
equivalent TCR levels (data not shown). These data sug-poorly understood. Here we present data characterizing
gested that the delivery of signals required to induceGRAIL function as an E3 ubiquitin ligase whose expres-
anergy was achieved within 4 hr of coculture and thatsion results in diminished gene transcription of the cyto-
at this 4 hr time point transcriptional changes could bekine IL-2. Our studies demonstrate that GRAIL localizes
observed in anergic T cells.to the transferrin recycling pathway and suggest a re-
quirement for intact endocytic processes in order to
GRAIL Is Expressed Early in the Induction of T Cellinhibit cytokine gene transcription.
Anergy In Vitro
In order to identify gene products specific to early eventsResults
in the induction of CD4 T cell anergy, we used the
in vitro model system described above and differentialT Cell Anergy Is Rapidly Induced In Vitro
display (ddPCR) to compare mRNA transcripts fromTo identify early gene products specific for the inductive
T cell clones following 4 hr anergizing, resting, and acti-events in anergy, we utilized a T cell- and APC-based
vating conditions. Of the five differentially displayed
system in vitro to induce phenotypic anergy, inhibition of
gene products confirmed by quantitative PCR (qPCR)
proliferation, and diminished IL-2 production following analysis to be expressed at higher levels in anergic T cell
recall antigen challenge (Ruberti et al., 1992). To function clones, only one transcript encoded an unknown protein
as surrogate APCs, RT 7.7 fibroblasts were transfected with low to undetectable constitutive transcript levels
to express the appropriate MHC in the presence or ab- in resting T cells (Figure 1C). A 32P-labeled gene fragment
sence of B7 to deliver either activating or anergy-induc- was used to screen a mouse anergic T cell library. A
ing signals, respectively. These surrogate APCs were 2145 bp cDNA clone encoding a 1287 bp open reading
cultured with the sperm whale myoglobin (SWM) reac- frame was identified and called GRAIL. Following in vitro
tive 3A T cell clone in the presence of B7 and SWM T cell, peptide, and surrogate APC coculture under an-
peptide (activating), the presence of peptide but ab- ergy-inducing conditions, GRAIL was rapidly tran-
sence of B7 (anergic), or in the presence of B7 but scribed. Northern blot analysis confirmed ddPCR data;
absence of peptide (resting). T cell clones cocultured GRAIL mRNA level increased as early as 4 hr by 5- to
under anergizing conditions for 4 or more hours, sepa- 7-fold in anergized cultures as compared to resting or
rated, rested, and rechallenged failed to proliferate (Fig- activated cells (Figure 1D).
ure 1A) and to produce IL-2 (data not shown). The addi-
tion of IL-2 to the reactivation cultures restored GRAIL Induction in Ionomycin-Treated Cells Is
proliferation (Figure 1B). These data suggest that ab- Calcineurin Dependent
sence of proliferation in cells activated for 4–6 hr with The calcium ionophore ionomycin has been previously
used to mimic early events in the induction of T cellsignal one in the absence of costimulation is a result of
GRAIL: An Anergy-Specific E3 Ligase Inhibits IL-2
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Figure 2. Kinetics of Ionomycin-Induced Tolerance and GRAIL Expression
(A) SWM T cell clone 2B was treated with 1.5 M ionomycin for increasing amounts of time (0, 6, and 18 hr) and rechallenged with conventional
APCs and peptide antigen in a standard proliferation assay.
(B) Proliferation after the addition of 5 U/ml recombinant murine IL-2 added to T cell clone 2B during 10 M antigen recall.
(C) Effect of cyclosporin A addition on mean stimulation index at 18 hr after ionomycin treatment.
(D) Quantitative PCR analysis of GRAIL expression in untreated 2B T cells, in the presence of 1.5 M ionomycin (0, 6, and 18 hr), 1.5 M
ionomycin plus 1 M cyclosporin A (6 and 18 hr), 1.5 M PMA  1.5 M ionomycin (6 hr).
(E) Western analysis of GRAIL expression in control untreated cells (lane 3) after 6 hr 1.5 M ionomycin treatment (lane 2) or in the presence
of 1.5 M ionomycin and 1 M cyclosporin A (lane 1). Anti-Jab loading control (below).
anergy (Macian et al., 2002). We additionally examined Using a polyclonal antibody raised against the C-ter-
minal GRAIL protein, we examined the kinetics of GRAILGRAIL expression in T cells made unresponsive through
ionomycin treatment. In cells treated with 1.5 M iono- induction at the protein level. We observed markedly
increased protein expression after 6 hr of ionomycinmycin for 6–18 hr, proliferation in response to antigen
rechallenge was markedly diminished at both time treatment. GRAIL protein expression was undetectable
in untreated T cells or in T cells treated with ionomycinpoints (Figure 2A). Addition of IL-2 to these cultures at
the time of antigen rechallenge restored proliferation to in the presence of cyclosporin A (Figure 2E).
levels comparable to those of untreated cells (Figure
2B). After 6 hr of ionomycin treatment, GRAIL transcript GRAIL Contains a Highly Conserved Zinc Binding
RING Fingerwas increased 3.3-fold compared to resting and acti-
vated cells by qPCR analysis and by 18 hr was rapidly Sequence analysis of the GRAIL cDNA revealed identity
to a mouse brain cDNA clone (GenBank accessionrestored to resting levels (Figure 2D). While ionomycin
treatment induced anergy and GRAIL expression in vitro, AB041548) that differed by a single nucleotide. The pre-
dicted translation product of GRAIL (Figure 3A) is a 428addition of 1 M cyclosporin A to ionomycin-treated
cells markedly reduced anergy induction (Figure 2C). amino acid protein that exhibits homology to several
zinc RING finger-containing proteins from mammalianWe noted in parallel cyclosporin A addition blocked
ionomycin-induced expression of GRAIL transcripts at 6 species as well as from a variety of invertebrate and
plant species including C. elegans, A. thaliana, and thehr. Moreover, T cells activated with PMA and ionomycin
also had minimal GRAIL transcript levels (Figure 2D). D. melanogaster Goliath (G1) protein. Homology is clus-
Immunity
538
Figure 3. Sequence Analysis of the GRAIL Protein and Multitissue Northern Expression
(A) The predicted amino acid sequence of GRAIL based on the longest open reading frame (428 aa).
(B) The predicted GRAIL protein sequence was multiply aligned (Clustal W) with other proteins containing Zinc RING finger domains including:
D. melanogaster Goliath, a mouse RING finger protein, a C. elegans homolog of Drosophila Goliath, a human hypothetical protein with similarity
to Goliath, and a mouse cDNA with similarity to Goliath called g1rp (g1-related protein). Only the region of highest homology containing the
Zinc RING domain is shown. Gray shading indicates identity, whereas black shading indicates similarity.
(C) A hypothetical GRAIL primary structure with putative protein motifs is shown.
(D) Northern blot analysis of GRAIL mRNA expression in mutliple murine tissues using an antisense full-length GRAIL probe.
tered in a stretch of approximately 75 residues in the hGRAIL (AF394689) with 97% amino acid identity to
murine GRAIL. Using various secondary structure pre-RING finger domain (Figure 3B), and this conservation
across diverse species suggested functional signifi- dictive algorithms, we identified other putative structural
motifs in addition to the zinc RING finger (C3H2C3 type)cance. Additionally, we cloned a human GRAIL homolog
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domain, including transmembrane, coiled-coil, and pro- used to examine its function in ligase activity. Substitu-
tion of two basic histidine residues with two basic aspar-tease-associated (PA) domains (Figure 3C). Analysis of
GRAIL expression in multiple tissues by Northern blot- agine residues that reside in the RING finger domain and
coordinate zinc binding (H2N2 GRAIL) entirely abolishedting revealed that, in addition to its expression in anergic
T cell clones, GRAIL message was found in tissues from autoubiquitination activity in vitro (Figure 4C). These
data suggested that E3 ligase activity required an intactbrain, kidney, heart, liver, ovary, testes, and thymus (Fig-
ure 3D). In vitro translated GRAIL, endogenous GRAIL RING finger domain. From these studies, we observed
that GRAIL fulfills two criteria for E3 ligase activity: theprotein from hepatocytes, and GRAIL protein induced
in anergic T cells was found to migrate between 62–66 ability to bind E2s and the ability to autocatalyze forma-
tion of higher molecular weight ubiquitin species in vitro.kDa. Glycosylation of GRAIL was demonstrated by tuni-
camycin treatment reducing GRAIL protein to a single A role for ubiquitination in the regulation of immune
responses recently has become more evident. Cbl-b,band migrating at 46 kDa (data not shown).
an E3 ligase, was demonstrated to be a negative regula-
tor of lymphocyte activation inhibiting TCR signalingGRAIL Demonstrates E3 Ligase Activity In Vitro
through PI3 kinase and blocking cytoskeletal rearrange-A number of RING finger-containing proteins have well-
ments downstream of CD28 signaling (Bachmeier et al.,characterized E3 ligase activity (cbl-b, anaphase pro-
2000; Chiang et al., 2002; Krawczyk et al., 2000; Fangmoting complex-cyclosome, Skp-1-cullin 1-F box). In
et al., 2001). Cbl-b was one of the five gene productsorder to test the functional significance of the C terminus
whose expression was increased in anergic cells (C.and RING domain, we performed a yeast two-hybrid
Seroogy et al., submitted) in the in vitro anergy assayscreen of a murine liver library because of high constitu-
and differential display described above. We now dem-tive GRAIL expression in liver (Figure 3D). Four murine
onstrate that GRAIL is an E3 ubiquitin ligase inducedhomologs of human E2 ubiquitin transferase proteins
under anergic conditions.were isolated by this procedure and identified by se-
quence analysis (data not shown). Therefore, we asked
whether GRAIL could function in vitro as an E3 ubiquitin GRAIL Inhibits Expression of IL-2 in T Cells
We identified GRAIL transcripts in anergic CD4 T cellsligase. During a ubiquitination reaction, ubiquitin is
transferred from the E1 ubiquitin-activating enzyme characterized by deficient IL-2 cytokine production. To
determine whether GRAIL expression was sufficient to(which forms the initial thiol-ester bond to ubiquitin) by
an E2 ubiquitin transferase enzyme to an E3 ubiquitin confer this phenotype, IL-2 production was assayed fol-
lowing TCR engagement in MBP reactive T cell hybrido-ligase/conjugase via direct binding of the E2 with the
E3 ligase. Substrate specificity is achieved via E3 ligase mas (ANTC) retrovirally transduced to express a cDNA of
GRAIL bearing a C-terminal v5 epitope tag. Transducedsubstrate binding, which results in the mono- or polyubi-
quitination of the bound substrate. Therefore, one crite- T cell hybridomas were generated that expressed either
wild-type or H2N2 RING finger mutant v5 tagged GRAILrion with which to evaluate E3 ligase activity is the ability
of the candidate E3 to directly bind an E2 ubiquitin trans- in the first cistron and GFP in the second cistron. The
viral IRES enabled efficient transcription of both the firstferase, while a second criterion is ATP-dependent cata-
lytic activity of ubiquitinating enzymes resulting in au- and second cistrons resulting in comparable bicistronic
transcription of GFP and GRAIL. T cell hybridomastoubiquitination (Hershko and Ciechanover, 1998;
Glickman and Ciechanover, 2002). transduced with vector, wild-type GRAIL, or H2N2
GRAIL were sorted by flow cytometry for equivalent GFPTo test the ability of GRAIL to directly bind E2 ubiqui-
tin-conjugating enzymes, GRAIL was expressed in E. and clonotypic TCR V8 expression. In T cell hybrido-
mas expressing wild-type GRAIL, we observed greatlycoli as a recombinant human GRAIL-GST fusion protein
lacking the signal sequence and the transmembrane reduced IL-2 production in response to anti-CD3 and
anti-CD28 antibody activation when compared to IL-2region. GRAIL-GST was bound to a column, and several
recombinant E2s were run over the column in pull-down production in the same T cell hybridomas transduced
with the vector control (Figure 5A). This inhibitory activityassays. Recombinant human GST-GRAIL bound several
recombinant E2s including E2-H5a (Figure 4A and data was lost in cells that expressed H2N2 mutant GRAIL
containing the two amino acid substitutions in the RINGnot shown). Given that recombinant GRAIL binds E2
ubiquitin-transferring enzymes, we addressed the ability finger domain. Following stimulation, H2N2 mutant-
transduced hybridomas exhibited IL-2 production com-of GRAIL to act as an E3 ligase when coexpressed with
these E2s in vitro by autocatalyzing the formation of parable to vector-transduced controls. Wild-type but
not H2N2 mutant GRAIL was also found to inhibit IL-4polyubiquitin chains. Autoubiquitinating activity of puri-
fied C-terminal GRAIL was examined in vitro through production following stimulation to less than 20% of
levels seen in activated cells expressing vector aloneexpression of recombinant human His-tagged E1, vari-
ous recombinant human E2s, ATP, and biotinylated ubi- (Figure 5B). RNase protection assay demonstrated that
this deficiency was due to diminished IL-2 and IL-4 tran-quitin, followed by Western blotting with avidin-peroxi-
dase. When hGRAIL-GST was assayed in the presence script levels (Figure 5C). To determine whether TCR
proximal signaling events were required to inhibit cyto-of E2-H5a or E2-H6 (and to a lesser extent with E2-
H2), we observed a characteristic laddering pattern that kine production in the presence of full-length GRAIL,
transduced T cell hybridomas were stimulated with PMAresults from progressive polyubiquitination and forma-
tion of higher molecular weight ubiquitin conjugates and ionomycin to bypass cell surface activation. Inhibi-
tion of both IL-2 (0.899 U/ml vector versus 0.146 U/ml(Figure 4B) in an E1- and ATP-dependent manner (Figure
4C). Mutation analysis of the RING finger domain was wild-type GRAIL) and IL-4 (0.073 ng/ml vector versus
Immunity
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Figure 4. In Vitro Ubiquitination Activity of Wild-Type but Not RING Finger Mutant GRAIL
(A) Wild-type recombinant human GST-tagged GRAIL lacking the signal sequence and transmembrane domain (lane 1), H2N2 RING finger
mutant recombinant C-terminal GST-tagged GRAIL lacking the signal sequence and transmembrane domain (lane 2), or GST alone (lane 3)
was incubated with S35-labeled in vitro translated E2-H5a. Pull-down assays were performed using beads and SDS-PAGE separation.
(B) Ubiquitination assays were performed using recombinant wild-type GST-tagged GRAIL lacking the signal sequence and transmembrane
domain along with an E1, biotinylated ubiquitin and ATP, and various recombinant human E2 enzymes.
(C) Recombinant wild-type (lane 1) and H2N2 RING finger mutant (lane 2) GST-tagged GRAIL lacking the signal sequence and transmembrane
domain, or GST alone (lane 3) was expressed in E. coli, purified and coincubated with an E1, E2 UbcH5a, biotinylated ubiquitin, and ATP (lane
1) or in the absence of ATP (lanes 4–6). Wild-type GST GRAIL was also assayed in the absence of either E2 (lane 7) or E1 (lane 8). Western
blots were probed with avidin-peroxidase.
0.001 ng/ml wild-type GRAIL) protein expression was distal to the cell surface. The subcellular localization
of GRAIL protein was analyzed by generating stableobserved (Figure 5D). Quantitative PCR analysis con-
firmed inhibition of IL-2 and IL-4 transcripts (data not retrovirally transduced NIH 3T3 cell lines in which v5
epitope-tagged GRAIL was expressed. Immunohisto-shown). Similar inhibition of IL-2 and IL-4 protein expres-
sion was seen in wild-type but not H2N2 mutant-express- chemistry revealed that GRAIL localized in an asymmet-
ric perinuclear punctate manner that partially coloca-ing Jurkat T cells, EL-4 T cells, and a collagen-reactive
hybridoma by cytokine ELISA (data not shown). These lized with the ER resident bip/GRP 78, with Golgi
resident syntaxin 5, and with the late endosomal GTPasedata suggest that GRAIL functions as an inhibitor of
cytokine gene transcription and that this activity is likely Rab7 (Figures 6A–6I). GRAIL localization closely associ-
ated with the recycling endosomal compartments de-to be mediated by E3-ligase activity.
fined by transferrin receptor recycling. In cells preincu-
bated for 1 hr at 4C to slow endosomal traffic, loadedGRAIL Is Localized to the Transferrin-Recycling
Endocytic Pathway with Texas Red-labeled transferrin at 4C for an addi-
tional hour, and then chased with 37C media to allowFrom sequence analysis, GRAIL is predicted to have
a putative signal peptide and single transmembrane- transferrin internalization for 30 min at 37C, GRAIL was
found to colocalize with transferrin (Figures 6J–6L). Us-spanning domain suggesting that GRAIL is a membrane-
bound protein. Based on functional assays, inhibition ing an anti-GRAIL rabbit-polyclonal antibody, it was
possible to compare localization in NIH 3T3 cells toof cytokine transcription in GRAIL-expressing cells still
occurred when cell surface-proximal membrane signal- endogenous GRAIL expression in H1 hepatocytes as
well as in the GRAIL-transduced T cell hybridoma linesing events were bypassed with PMA-ionomycin activa-
tion, suggesting that GRAIL activity was likely to occur used in the cytokine assays. All cells exhibited a similar
GRAIL: An Anergy-Specific E3 Ligase Inhibits IL-2
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Figure 5. Wild-Type but Not RING Finger Mutant GRAIL Inhibits IL-2 and IL-4 Production
(A) T cell hybridomas were transduced to express GFP alone (empty vector) (right), GFP and wt GRAIL (left), or GFP and H2N2 RING finger
mutant GRAIL (middle) and sorted for equivalent TCR and GFP expression. Sorted T cells were assayed for IL-2 by ELISA 18–24 hr after
stimulation with plate-bound anti-CD3 and anti-CD28 antibodies (5 g/ml of each). Data show the mean of six independent experiments in
which triplicate ELISA wells were assayed per experiment and show relative ratio to vector.
(B) IL-4 ELISA; one representative experiment of three with triplicate values assayed per well.
(C) RNase protection assay using extracted mRNA from T cell hybridomas 4 hr after stimulation with plate-bound anti-CD3 and anti-CD28
antibody (lanes 4–6: WT, H2N2, vector) or unstimulated controls (lanes 1–3: WT, H2N2, vector). L32 and GAPDH loading controls are shown
below.
(D) IL-2 and IL-4 ELISA for cells treated with 1 g/ml PMA  1g/ml ionomycin for 6 hr.
GRAIL staining pattern (see supplemental data at http:// 535/DC1). We stimulated cells with anti-CD3 and anti-
CD28 in the presence or absence of latrunculin B, awww.immunity.com/cgi/content/full/18/4/535/DC1).
drug demonstrated to increase coated pit mobility at
low doses and to disrupt endocytic sorting of transferrinGRAIL Inhibition of Cytokine Gene Transcription Is
Dependent upon Intact Endocytic Traffic through actin-monomer sequestration (Gadairov et al.,
1999; Sheff et al., 2002). Latrunculin B addition entirelyIn contrast to antibody or PMA-ionomycin activation,
we observed that activation of T cell hybridomas with abolished GRAIL-mediated IL-2 inhibition (Figure 7C),
further suggesting a requirement for actin-based endo-2.5g/ml concanavalin A (Con A) in the presence of freshly
irradiated APCs resulted in comparable IL-2 production cytic sorting.
between GRAIL, H2N2 GRAIL, and vector-expressing
cells (Figure 7A). Furthermore, addition of ConA to hy- Discussion
bridomas stimulated on plate-bound anti-CD3 and anti-
CD28 minimized the observed differences in IL-2 pro- We have identified and characterized GRAIL, an E3 ubi-
quitin ligase whose expression is rapidly induced in an-duction (Figure 7B). In light of GRAIL localization and
because in addition to mitogenic properties Con A effi- ergic T cells. While a requirement for the synthesis of
new proteins and intact calcineurin activity in the induc-ciently inhibits clathrin-mediated endocytosis and G pro-
tein-coupled receptor internalization (Hansen et al., 1993, tion of T cell anergy has been reported, no proteins have
been identified in anergic CD4 T cells that are notGicquiaux et al., 2002; Budd et al., 1999; DeGraff et al.,
1999), we hypothesized that GRAIL activity might require expressed at significant constitutive levels in resting
T cells and that are also induced in a calcineurin-depen-intact endosomal traffic and that the IL-2 production
observed might be due to ConA inhibition of endocyto- dent fashion. We observed that GRAIL expression alone
recapitulates certain hallmarks of the anergic pheno-sis. In T cell hybridomas treated with ConA, endocytosis
of transferrin was efficiently blocked (see supplemental type, dramatically limiting the transcription of both the
IL-2 and IL-4 genes. These cytokine genes (whose pro-data at http://www.immunity.com/cgi/content/full/18/4/
Immunity
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Figure 6. GRAIL Localizes to the Internal Pool of the Transferrin Recycling Endosomal Pathway
(A) NIH 3T3 retrovirally transduced lines expressing wild-type GRAIL with a C-terminal v5 epitope tag were used for immunofluorescence
analysis of subcellular GRAIL (100 oil). Confocal secions of .5 M were taken at 100 magnification of NIH 3T3 cells costained (C, F, and
I) for GRAIL-v5 (B, E, and H) and anti-GRP78 (ER) (A), anti-syntaxin 5 (Golgi) (D), or anti-Rab7 (late endosomes) (G). Recycling endosomal
localization in NIH 3T3 cells was assayed after transferrin uptake for 30 min. Shown are .5 M confocal sections for GRAIL-V5 (K) and Texas
Red-transferrin (J), with overlay (L).
GRAIL: An Anergy-Specific E3 Ligase Inhibits IL-2
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Figure 7. GRAIL Does Not Inhibit IL-2 Production in T Cells When Endocytosis Is Inhibited
(A) IL-2 cytokine ELISA of wild-type GRAIL, H2N2 GRAIL, and vector-expressing T cells stimulated with ConA and APCs. Shown is the mean
relative ratio to vector from three independent experiments.
(B and C) Anti-CD3 and anti-CD28 in the presence (gray bars) or absence (black bars) of 2.5 g/ml ConA (B) or .1 g/ml Latrunculin B. (C)
One representative experiment of three is shown with triplicate wells assayed.
moters synergistically integrate activity of NFAT and pathways via monoubiquitination (Cenciarelli et al.,
1992; Rocca et al., 2001). The induction of E3 ligaseAP-1 downstream of independent signals) were pre-
viously demonstrated to be induced downstream of TCR expression and regulation of T cell anergy induction via
the ubiquitin proteosome system is one posttransla-and CD28 signaling (DeSilva et al., 1996; Seder et al.,
1994; June et al., 1994). Consistent with a functional tional mechanism of protein regulation that may help
explain the earlier findings that fusion of anergic cellsassociation of GRAIL expression and T cell anergy in
vitro, our lab has recently described GRAIL transcript to transformed Jurkat T cells did not rescue signaling
defects but rather transferred IL-2 transcriptional re-upregulation in a CD25 suppressor in vitro model sys-
tem (Ermann et al., 2001) as well as in two classic models pression.
In view of the ability of wild-type but not H2N2 mutantof T cell anergy induction in vivo (C. Seroogy et al.,
submitted). GRAIL to function as an E3 ligase and to inhibit cytokine
gene transcription, GRAIL inhibition of IL-2 expressionMechanisms suggested for anergy induction and
maintenance included the transcriptional regulation of is likely to occur through GRAIL-mediated substrate ubi-
quitination. Specificity in ubiquitin-mediated processescytokines, inhibition of cell cycle progression, and
blockade of intracellular signaling. More recently, a role is achieved by E3 binding of target substrates. Identifi-
cation of the target(s) of GRAIL ubiquitination will likelyfor ubiquitin-related mechanisms has emerged in T cells,
highlighted by the regulation of phosphatidyl-inositol 3 uncover novel mechanisms of cytokine transcriptional
regulation, such as those seen in T cell anergy. Wekinase in lymphocytes by the E3 ubiquitin ligase Cbl-b
(Fang et al., 2001). Cbl-b-deficient mice develop sponta- have demonstrated an association between intact actin-
driven endocytic transport and GRAIL-mediated inhibi-neous autoimmunity as demonstrated by autoantibody
production, organ infiltration by T and B cells, and T cell tion of cytokine gene transcription, suggesting that
GRAIL function is intimately tied to this compartment.hyperproduction of IL-2 independent of CD28-mediated
signaling (Bachmeier et al., 2000). In addition to more GRAIL mutants, including H2N2, which no longer impact
cytokine gene transcription, demonstrate markedly al-traditional roles in targeting substrates for proteosome-
mediated degradation via ubiquitination, E3 ubiquitin tered subcellular localization (see supplemental data at
http://www.immunity.com/cgi/content/full/18/4/535/ligases have recently been shown to alter ligand-medi-
ated signaling in T cells by targeting cell surface recep- DC1) lending further support to localization-dependent
function.tors, including TCR and IL-2R chain, into recycling
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Ubiquitin-mediated regulation of endocytic sorting NIH 3T3 fibroblasts results in filopodia formation, mem-
and internalization has been reported in S. cerevisiae brane ruffling, and other actin-related phenotypes (see
and is likely to serve a homologous function in mamma- supplemental data at http://www.immunity.com/cgi/
lian species (Hicke, 2001). While the internalization of a content/full/18/4/535/DC1). We have also identified in
large number of mammalian cell surface receptors is preliminary studies binding of GRAIL and Rit, a ras-
driven by ubiquitination, very few mammalian E3 ligases related membrane-associated GTPase (Lee et al., 1996)
have actually been demonstrated to localize to endoso- whose constitutive activity results in actin-based pheno-
mal compartments. Endosomal turnover provides a types such as neurite outgrowth (Spencer et al., 2002). In
highly efficient means of rapidly reorganizing signaling this model, GRAIL-mediated ubiquitination of substrate
complexes (Di Fiore and De Camilli, 2001). Kinetic stud- might occur within a macromolecular, endosomal com-
ies have demonstrated a half-time of 7–8 min for trans- plex which may serve to link or unlink adaptor molecules
ferrin recycling (Edwards et al., 1996). We observe to the cytoskeleton or endosomes.
GRAIL localization in the transferring-recycling pathway, Given the conserved domain homology of GRAIL to
through which surface expression of a number of T cell RING finger proteins across mammalian, plant, and in-
signaling molecules are regulated, including the TCR vertebrate species, it is likely that these other RING
(Salmeron et al., 1995; Alcover and Alarcon, 2000), finger-containing proteins may also function as E3 li-
CTLA-4 (Bradshaw et al., 1997; Chuang et al., 1997), gases in signaling pathways. The function of Goliath and
and lck (Richie-Ehrlich et al., 2002). That GRAIL has an Goliath-related homologs of GRAIL is unclear; however,
N-terminal protease-associated domain, a motif origi- they appear to be critical in numerous developmental
nally defined by transferrin receptor sorting and involved processes. Restricted Goliath expression has been ob-
in plant vacuolar sorting pathways, further supports a served in the developing mesodermal tissues of Dro-
possible sorting function (Luo and Hofmann, 2001; Cao sophila (Bouchard and Cote, 1993), and increased ex-
et al., 2000). pression of g1rp (g1-related protein) has been observed
A potential mechanism by which GRAIL might inhibit during IL-3 growth-factor withdrawal-induced apoptosis
the delivery of mitogenic signals could be through activ- of myeloid precursor cells (Baker and Reddy, 2000).
ity analogous to that demonstrated for Cbl: selective A role for GRAIL E3 ligase activity in developmental
targeting of tyrosine phosphorylated proteins into the processes is supported by the findings of Borchers et
endocytic pathway via ubiquitination. In this model, al. (2002) who observe that GRAIL expression in Xeno-
GRAIL-mediated ubiquitination may promote substrate pus can sensitize ectoderm to neuralizing signals re-
sequestration toward or away from a subcellular com- sulting in conversion of ectoderm to an anterior fate.
partment as a means of terminating signaling. That GRAIL is induced in a highly regulated manner
A second possible mechanism for GRAIL regulation in peripheral CD4 T cells while constitutive GRAIL ex-
of mitogenic signal delivery could be through GRAIL- pression is observed in the CNS, kidney, and liver sug-
mediated ubiquitination of substrate, resulting in sub- gests tissue-specific substrate interactions, regulation
strate degradation via the proteosome. GRAIL is a type of GRAIL itself at a posttranslational level, or, most in-
I transmembrane protein, suggesting that its N-terminal triguingly, that the program of T cell anergy is similar
protease-associated domain would be internal to an to regulatory pathways in these organs. Understanding
endocytic vesicle and that the C terminus C3H2C3 RING GRAIL function in concert with other anergy-specific
finger domain would project into the cytosolic lumen. genes will expose the functional mechanisms that un-
This positioning affords the possibility of its interaction derlie anergy induction in T cells. In light of GRAIL E3
with numerous cytosolic proteins that may be substrates ligase activity, endocytic residence, and domain homol-
for ubiquitination and degradation. ogy, understanding GRAIL function and substrate asso-
The coordinated regulation of mitogenic signaling on ciation is likely to reveal highly conserved mechanisms
endosomes has been established for several signaling
for rapidly altering cell fate in diverse cellular contexts.
pathways, including components of those pathways
downstream of CD28 such as JNK and WASP (Cavalli Experimental Procedures
et al., 2001; Di Fiore and De Camille, 2001). CD28 costi-
mulation mediates actin reorganization resulting in pro- Cell Lines and Culture
T cell clones were carried in RPMI-C media and restimulated withductive synapse formation through activation of the
freshly irradiated DBA/2 splenocytes and 10 M SWM peptide everyWASP-Vav-CDC42 pathway and is intimately tied to en-
10–14 days. T cell clone 11.3.7 has been described (Ruberti et al.,docytic traffic via Rho family GEF proteins (Costello et
1992). The RT 7.7 fibroblast cell line transfected with the mixedal., 1999), adaptor molecules such as intersectin-2
isotype (EadAad) MHC class II gene and the B7-1 cDNA construct
(McGavin et al., 2001), and the actin cytoskeleton (Silvin pL444-mB7 used to generate a B7 () RT 7.7 line by stable transfec-
et al., 2001; Zhang et al., 1999; Snapper et al., 1998). tion were kindly provided by Dr. Germain (NIH, Bethesda, MD).
Thus, a third possible model would have GRAIL regulate
events linking endocytosis and actin reorganization that Fibroblast Anergy Assays
act upstream of cytokine transcription, as has been B7 () RT 7.7 fibroblasts (anergic) or costimulatory competent, B7
() RT7.7 APCs (activated, resting) were irradiated at 3000 radsshown for Vav/Slp 76 activity in which IL-2 transcription
prior to use in anergy assays and mixed at a 1:1 ratio with SWMindependent of MAPK activity may occur (Raab et al.,
T cell clones 11.3.7 or 3A in RPMI-C media in the presence (anergic,2001). Consistent with such a model, we did not observe
activated) or absence (resting) of 10 M SWM 110-121 peptide. At
any differences in the activation status of p38, JNK, or selected time intervals, aliquots of cultures were mixed with anti-
ERK1/2 in GRAIL-expressing cells (L. Su and C.G.F., CD4 microbeads (Miltenyl Biotech) to separate CD4 T cells from
unpublished data). Furthermore, we have observed that fibroblast APCs; T cells were rested 24 hr. To test for anergy, 5 
105 T cells were cultured with .5 106 irradiated DBA/2 splenocytesthe expression of GRAIL zinc finger deletion mutants in
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and 0–10 M peptide in triplicate wells of a 96-well plate. In selected Ubiquitination Assays
Ubiquitination assays were performed as described (Huang et al.,cultures, murine rIL-2 (Genzyme) was added at 5 units/ml during
restimulation to test viability. After 54 hr, the cells were pulsed for 2000), with some modifications. Ten microliter reactions contained
100 nM human His-tagged E1 (Calbiochem), 1 M E2 enzyme (Bos-18 hr with 3H-thymidine and counted in a -counter.
ton Biochemicals), 5 M biotinylated-ubiquitin, 2 mM ATP, and 1
g of either GST-GRAIL, GST-GRAIL H2N2, or GST alone in bufferIonomycin Anergy
(50 mM Tris-HCl [pH 7.6], 2 mM MgCl2, and 1 mM DTT). ReactionsSWM T cell clone 2B was treated for 0, 1, 6, or 18 hr with 1.5 M
were incubated at 25C for 60 min and terminated by the additionionomycin (Sigma) at 37C, with 1.5 M PMA (Sigma) and 1.5 M
of reducing Laemli sample buffer. Samples were resolved on a 4%–ionomycin, or with 1.5 M ionomycin and 1 M cyclosporin A for 6
12% gradient polyacrylamide gel (NuPage).hr and 18 hr. Cells were washed and cell pellets were prepared for
quantitative PCR or Western blot analysis. To test for anergy, 5 
Pull-Down Assays105 T cell clones were tested by proliferation as described above.
Bacterial expressed GST-GRAIL isoforms (2 g) were incubated
with 1  105 cpm of S35-labeled in vitro translated E2-H5a (TNT-T7)
Differential Display
(Promega). Reactions were rotated for 2 hr at 4C. Glutathione-
RNA was isolated from 11.3.7 T cells treated under resting, activat-
agarose beads were added for an additional 2 hr. Beads were col-
ing, or anergic conditions (Qiagen) and reverse transcribed for differ-
lected by centrifugation, washed three times in PBS-0.1% NP-40,
ential display PCR (Genomyx). Templates were amplified for 40 cy-
and boiled for 3 min in Laemli sample buffer. Samples were run on
cles in the presence of 35S-dATP. cDNA fragments present at higher
a 12% SDS-PAGE, and the gel was fixed. Detection of radioactive
levels in anergic lanes were gel excised, reamplified for TA cloning
E2-H5a was captured using a Phosphor Imager (Bio-Rad).
(Invitrogen), and sequenced.
Retroviral Transduction
Real-Time Quantitative PCR The ANTC T cell hybridoma was previously described (Nakajima et
Standard RNA isolation, reverse transcription, and PCR protocols al., 2001). P3 constructs were transfected into 293 phoenix packag-
were used (ABI 5700, Applied Biosystems). GRAIL primers and fluo- ing cells using standard calcium phosphate transfection to generate
rogenic probes were designed to span intron-exon regions. Probes virus containing either the P3 vector alone, the FL-P3 vector con-
and primer sets specific for normalizing gene 18S rRNA were used taining the 1.3 kB GRAIL open reading frame and v5 epitope tag
(Applied Biosystems). PCR was performed in triplicate on test sam- (Invitrogen), or with the mH2N2-P3 vector identical to FL-P3 but with
ples and murine liver cDNA standards allowing changes in GRAIL histidine 297 and 300 substituted with arginine. In PMA-ionomycin
RNA to be quantitated and normalized to rRNA levels. GRAIL arbi- experiments, ANTC lines were used expressing GRAIL in the pGC-
trary units (aU) is GRAIL quantity expressed as the mean of triplicate IRES vector. Cells were retrovirally transduced by standard proto-
normalized values  standard deviation. cols and sorted every 4 weeks for equivalent TCR and GFP expres-
sion between vector, wt GRAIL, and H2N2 mutant-expressing lines.
Cloning of the GRAIL cDNA Wild-type GRAIL-P3, H2N2-P3, and empty P3 backbone vectors
Poly A mRNA isolated from anergized 11.3.7 T cells was sent to were also used for transduction of NIH 3T3 cell lines.
Stratagene for cDNA library construction. Phage plaques were
screened with a 32P-labeled ddPCR fragment, and positive clones ELISA
were sequenced (Stanford PAN facility). The longest positive clone Cells from ANTC lines P3, FL, and mH2N2 were seeded at 8  105
was 2145 bp and contained an ORF of 1284 bp (clone 25-3 pBKCMV). cells/ml 48 hr prior to use. After 48 hr, 4  105 cells/ml cells were
Sequence comparisons between GRAIL and related proteins were seeded for antibody stimulation into 1 ml RPMI-C onto a 6-well
done using EXPASY and NCBI-Blast. Drosophila Goliath (G1) protein precoated with 5 g/ml anti-CD3 and anti-CD28 antibodies (BD
(AAA28582) (35% identity over 191 amino acids (aa), mouse g1- Pharmingen). ELISA supernatants were harvested at 18–24 hr. For
related protein (g1rp) (AAF05310) (41%, 315 aa), the uncharacterized PMA-ionomycin stimulation, 1  106 cells/ml cells were seeded in
human KIAA1214 protein (BAA86528) (38%, 354 aa), an uncharacter- RPMI-C with 1 g/ml PMA plus 1 g/ml ionomycin; supernatants
ized C. elegans protein (AAC26923) (32%, 193 aa), and a mouse were harvested at 6 hr. Europium Sandwich ELISA (Pharmingen and
RING zinc finger protein (AAC03770) (24% identity, 336 aa) were Wallac) was performed on triplicate wells in 96-well plates (Nunc).
aligned. Secondary structural predictions were made using algo- Based on standard curves, the lower limits of detection were 0.078
rithms available at the ExPASY website and conserved domain data- units/ml for IL-2 and .01 ng/ml for IL-4. Actual experimental values
base at NCBI. for IL-2 ranged between .15 and 2.5 U/ml activity and for IL-4 be-
tween .0001 (below detectable limits) and .1 ng/ml under anti-CD3
anti-CD28 stimulation conditions.Western Blot Analysis of GRAIL Expression
Recombinant C-terminal GRAIL protein was expressed in bacteria
RPAas a GST fusion (pET41 vector, Novagen); purified protein was used
The Riboquant Multiprobe RNase Protection System was used to gen-to produce rabbit polyclonal antiserum (Zymed). Affinity-purified
erate mouse cytokine probe mCK-1, and standard Riboquant proce-rabbit polyclonal antibody against GRAIL was screened against he-
dures (Pharmingen) were used to detect products in 5 g total RNA.patocyte and GRAIL-expressing T cell hybridomas by Western blot
and immunofluorescence analysis. Brij 96V lysis buffer was used
for cell lysis. Immunofluorescence
See Supplemental Experimental Procedures at http://www.immunity.
com/cgi/content/full/18/4/535/DC1.Northern Blot Analysis of GRAIL Expression
Northern analysis was performed on total RNA from 11.3.7 T cells
Concanavalin A and Latrunculin B Treatmenttreated for 4 hr under resting, activating, or anergizing conditions.
1  106 ANTC cells were seeded with 6–8  106 B10.PL femaleMembranes were hybridized with a 1.8 kb random-primed 32P-labeled
(Jackson) irradiated splenocytes in the presence of 2.5g/ml conca-GRAIL cDNA fragment according to standard protocols, stripped,
navalin A (Sigma). For anti-CD3, anti-CD28 activation cells wereand reprobed with the DECAprobe-GAPDH-Mouse cDNA fragment
cultured with anti-CD3 and anti-CD28 as described above but with(Ambion) to assess loading. For multitissue analysis, GRAIL ORF
addition of either 2.5 g/ml concanavalin A or .1 g/ml Latrunculin B.cDNA was cloned into pCR4 (Invitrogen) and linearized, and 32P-UTP-
labeled antisense transcripts were generated using T3 polymerase
(StripAble RNA probe synthesis, Ambion). Full-length antisense Acknowledgments
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